Research Papers

25 of 3340 papers

CSV Excel
Quick filters: Open Data Open Code Pre-registered Funding Declared COI Declared Open Access Clear Filters
Multicenter Experience with Good Manufacturing Practice Production of [<sup>11</sup>C]PiB for Amyloid Positron Emission…
Andersen ABA; Lehel S; Grove EK; Langkjaer N; Fuglø D; Huynh THV.
Pharmaceuticals (Basel) (Unknown)
Published: 2024
3/6 Transparent
Funding Declared
Dynamic Changes in Adiponectin and Resistin Drive Remission of Cardiometabolic Risk Biomarkers in Individuals with Obes…
Fiorotti AM; Gomes ACA; Bortoli AM; Brito BB; Nunes KZ; Haraguchi FK; Bolsoni-Lopes A.
Pharmaceuticals (Basel) (Unknown)
Published: 2024
3/6 Transparent
Funding Declared
A Review of Current and Pipeline Drugs for Treatment of Melanoma.
Natarelli N; Aleman SJ; Mark IM; Tran JT; Kwak S; Botto E; Aflatooni S; Diaz MJ; Lipner SR.
Pharmaceuticals (Basel) (Unknown)
Published: 2024
3/6 Transparent
Funding Declared
Nanophytosomal Gel of <i>Heydotis corymbosa</i> (L.) Extract against Psoriasis: Characterisation, In Vitro and In Vivo …
Singh N; Shaikh AM; Gupta P; Kovács B; Abuzinadah MF; Ahmad A; Goel R; Singh S; Vinayak C.
Pharmaceuticals (Basel) (Unknown)
Published: 2024
3/6 Transparent
Funding Declared
Integrating Artificial Intelligence and PET Imaging for Drug Discovery: A Paradigm Shift in Immunotherapy.
McGale JP; Howell HJ; Beddok A; Tordjman M; Sun R; Chen D; Wu AM; Assi T; Ammari S; Dercle L.
Pharmaceuticals (Basel) (Unknown)
Published: 2024
3/6 Transparent
Funding Declared
Antibacterial Potential of Symmetrical Twin-Drug 3,6-Diaminoxanthones.
Resende DISP; Durães F; Zubarioglu S; Freitas-Silva J; Szemerédi N; Pinto M; Pinto E; Martins da Costa P; Spengler G; Sousa E.
Pharmaceuticals (Basel) (Unknown)
Published: 2024
3/6 Transparent
Funding Declared
Structure-Based In Silico Approaches Reveal IRESSA as a Multitargeted Breast Cancer Regulatory, Signalling, and Recepto…
Almasoudi HH; Mashraqi MM; Alshamrani SA; Alharthi AA; Alsalmi O; Nahari MH; Al-Mansour FSH; Alhazmi AYM.
Pharmaceuticals (Basel) (Unknown)
Published: 2024
3/6 Transparent
Funding Declared
COVID-19 Distribution in Pregnancy, Drug Use Patterns and COVID-19 Medication during the Pandemic in Spain: Data from R…
Mota-Pérez M; Huerta-Álvarez C; Llorente A; Cea-Soriano L.
Pharmaceuticals (Basel) (Unknown)
Published: 2024
3/6 Transparent
Funding Declared
Risk Factors for Respiratory Depression Associated with Tramadol Based on the Global Pharmacovigilance Database (VigiBa…
Park S; Lee GH; Kim S; Kim S; Kim Y; Choi SA.
Pharmaceuticals (Basel) (Unknown)
Published: 2024
3/6 Transparent
Funding Declared
Efficacy of Ceragenins in Controlling the Growth of Oral Microorganisms: Implications for Oral Hygiene Management.
Czarnowski M; Słowińska M; Sawieljew M; Wnorowska U; Daniluk T; Król G; Karasiński M; Okła S; Savage PB; Piktel E; Bucki R.
Pharmaceuticals (Basel) (Unknown)
Published: 2024
3/6 Transparent
Funding Declared
Identification of Factors Associated with Mortality in the Elderly Population with SARS-CoV-2 Infection: Results from a…
Birlutiu V; Neamtu B; Birlutiu RM.
Pharmaceuticals (Basel) (Unknown)
Published: 2024
3/6 Transparent
Funding Declared
The Effect of a <i>Tribulus</i>-Based Formulation in Alleviating Cholinergic System Impairment and Scopolamine-Induced …
Bouabdallah S; Brinza I; Boiangiu RS; Ibrahim MH; Honceriu I; Al-Maktoum A; Cioanca O; Hancianu M; Amin A; Ben-Attia M; Hritcu L.
Pharmaceuticals (Basel) (Unknown)
Published: 2024
3/6 Transparent
Funding Declared
Discovery of Pyrano[2,3-<i>c</i>]pyrazole Derivatives as Novel Potential Human Coronavirus Inhibitors: Design, Synthesi…
Allayeh AK; El-Boghdady AH; Said MA; Saleh MGA; Abdel-Aal MT; Abouelenein MG.
Pharmaceuticals (Basel) (Unknown)
Published: 2024
3/6 Transparent
Funding Declared
A Comprehensive Immunocapture-LC-MS/MS Bioanalytical Approach in Support of a Biotherapeutic Ocular PK Study.
Chen LZ; Roos D; Philip E; Werth EG; Kostuk S; Yu H; Fuchs H.
Pharmaceuticals (Basel) (Unknown)
Published: 2024
3/6 Transparent
Funding Declared
Proportion of Over-The-Counter Medicines Containing a Plant Component and Those with Synthetic Substances Administered …
Hadzhieva B; Petkova-Dimitrova V.
Pharmaceuticals (Basel) (Unknown)
Published: 2024
3/6 Transparent
Funding Declared
First Insights on the Bioaccessibility and Absorption of Anthocyanins from Edible Flowers: Wild Pansy, Cosmos, and Corn…
Teixeira M; De Luca L; Faria A; Bordiga M; de Freitas V; Mateus N; Oliveira H.
Pharmaceuticals (Basel) (Unknown)
Published: 2024
3/6 Transparent
Funding Declared
Chirality and Rigidity in Triazole-Modified Peptidomimetics Interacting with Neuropilin-1.
Fedorczyk B; Redkiewicz P; Matalińska J; Piast R; Kosson P; Wieczorek R.
Pharmaceuticals (Basel) (Unknown)
Published: 2024
3/6 Transparent
Funding Declared
Sulfadiazine Exerts Potential Anticancer Effect in HepG2 and MCF7 Cells by Inhibiting TNFα, IL1b, COX-1, COX-2, 5-LOX G…
Gomaa M; Gad W; Hussein D; Pottoo FH; Tawfeeq N; Alturki M; Alfahad D; Alanazi R; Salama I; Aziz M; Zahra A; Hanafy A.
Pharmaceuticals (Basel) (Unknown)
Published: 2024
3/6 Transparent
Funding Declared
Antimicrobial Evaluation of Sulfonamides after Coupling with Thienopyrimidine Coplanar Structure.
Elmongy EI; Alanazi WS; Aldawsari AI; Alfaouri AA; Binsuwaidan R.
Pharmaceuticals (Basel) (Unknown)
Published: 2024
3/6 Transparent
Funding Declared
Hybrid Molecules of Azithromycin with Chloramphenicol and Metronidazole: Synthesis and Study of Antibacterial Propertie…
Volynkina IA; Bychkova EN; Karakchieva AO; Tikhomirov AS; Zatonsky GV; Solovieva SE; Martynov MM; Grammatikova NE; Tereshchenkov AG; Paleskava A; Konevega AL; Sergiev PV; Dontsova OA; Osterman IA; Shchekotikhin AE; Tevyashova AN.
Pharmaceuticals (Basel) (Unknown)
Published: 2024
3/6 Transparent
Funding Declared
Biopolymeric Nanogel as a Drug Delivery System for Doxorubicin-Improved Drug Stability and Enhanced Antineoplastic Acti…
Radeva L; Zaharieva MM; Spassova I; Kovacheva D; Pencheva-El Tibi I; Najdenski H; Yoncheva K.
Pharmaceuticals (Basel) (Unknown)
Published: 2024
3/6 Transparent
Funding Declared
Application of NIR Spectroscopy for the Valorisation of Cork By-Products: A Feasibility Study over the Screening and Di…
Páscoa RNMJ; Pinto C; Rego L; Silva JRE; Tiritan ME; Cidade H; Almeida IF.
Pharmaceuticals (Basel) (Unknown)
Published: 2024
3/6 Transparent
Funding Declared
Early Stage Preclinical Formulation Strategies to Alter the Pharmacokinetic Profile of Two Small Molecule Therapeutics.
An L; De Bruyn T; Pang J; Ubhayakar S; Salphati L; Zhang X; Liu L; Li R; Chan B; Dey A; Levy ES.
Pharmaceuticals (Basel) (Unknown)
Published: 2024
4/6 Transparent
Data Funding Declared
Antipsychotics and Risks of Cardiovascular and Cerebrovascular Diseases and Mortality in Dwelling Community Older Adult…
Perreault S; Boivin Proulx LA; Brouillette J; Jarry S; Dorais M.
Pharmaceuticals (Basel) (Unknown)
Published: 2024
3/6 Transparent
Funding Declared
Enhancing Ocular Surface in Dry Eye Disease Patients: A Clinical Evaluation of a Topical Formulation Containing Sesquit…
Ng D; Altamirano-Vallejo JC; Navarro-Partida J; Sanchez-Aguilar OE; Inzunza A; Valdez-Garcia JE; Gonzalez-de-la-Rosa A; Bustamante-Arias A; Armendariz-Borunda J; Santos A.
Pharmaceuticals (Basel) (Unknown)
Published: 2024
3/6 Transparent
Funding Declared